Jetbest Corporation AI Stock Analysis
Jetbest Corporation (4741) AI Stock Analysis
Jetbest Corporation
(TPEx:4741)
Jetbest scores in the middle of the range, held back primarily by deteriorating fundamentals: four straight years of falling revenue, an operating margin down to 1.1%, an 85% drop in net profit, and free cash flow that has all but evaporated. A very conservative balance sheet — minimal debt and equity funding over 80% of assets — provides meaningful downside protection but is currently generating only ~1% return on equity. Strong technicals are the main positive, with the share price well above all key moving averages and a firmly positive MACD, although the stochastic reading signals the move is becoming extended. Valuation is the other drag: a P/E of 49.2 on depressed earnings paired with a 0.52% dividend yield leaves little margin for disappointment. A stabilization in revenue and gross margin recovery would be the key catalysts for a higher score.
Jetbest Corporation (4741) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 2.04B
- Dividend Yield
- 0.50%
- Average Volume (3M)
- 578.22K
- Price to Earnings (P/E)
- 42.9
- Beta (1Y)
- 0.60
- Revenue Growth
- 5.77%
- EPS Growth
- 157.11%
- Country
- TW
- Employees
- 98
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Jetbest Corporation Business Overview & Revenue Model
Company Description
Jetbest Corporation is a global enterprise focused on the research, development, manufacturing, and distribution of inkjet printing products, serving markets in Taiwan and worldwide. Their extensive product line encompasses a diverse array of inks, i...
Jetbest Corporation Financial Statement Overview
Summary
Mixed profile dominated by operational deterioration. The income statement (score 33) is the weak link: four consecutive years of revenue decline to NT$484.9m, operating margin collapsing to 1.1%, and net income down ~85% to NT$10.1m, with profit now reliant on non-operating items. Cash flow (score 45) has also weakened sharply — operating cash flow fell to NT$36.7m and free cash flow to NT$9.2m, covering only about a quarter of net income. The offset is a fortress balance sheet (score 79): equity funds 82% of assets, debt-to-equity is just 0.11, providing real downside protection, though ROE has fallen to roughly 1%, showing that capital is badly underutilized.
Income Statement
33NegativeBalance Sheet
79PositiveCash Flow
45Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 525.23M | 484.90M | 590.08M | 648.57M | 724.51M | 630.20M |
| Gross Profit | 172.41M | 131.25M | 202.78M | 200.86M | 178.10M | 159.10M |
| EBITDA | 78.77M | 51.94M | 125.60M | 116.48M | 104.14M | 76.89M |
| Net Income | 42.04M | 10.11M | 65.26M | 66.20M | 55.13M | 29.67M |
Balance Sheet | ||||||
| Total Assets | 1.15B | 1.12B | 1.14B | 1.17B | 1.17B | 1.17B |
| Cash, Cash Equivalents and Short-Term Investments | 364.67M | 359.75M | 375.86M | 382.89M | 278.91M | 230.28M |
| Total Debt | 98.33M | 97.45M | 83.88M | 95.59M | 92.63M | 121.10M |
| Total Liabilities | 219.38M | 197.70M | 189.80M | 223.71M | 235.16M | 260.23M |
| Stockholders Equity | 928.48M | 910.55M | 939.97M | 933.96M | 913.61M | 885.31M |
Cash Flow | ||||||
| Free Cash Flow | 20.02M | 9.23M | 72.10M | 145.02M | 100.42M | -38.15M |
| Operating Cash Flow | 38.39M | 36.66M | 110.01M | 156.67M | 103.46M | 57.13M |
| Investing Cash Flow | -114.22M | -123.56M | -40.86M | -9.36M | -2.83M | -91.86M |
| Financing Cash Flow | -33.11M | -25.65M | -76.15M | -41.52M | -53.38M | 4.92M |
Jetbest Corporation Peers Comparison
Overall Rating
TW:652773Outperform
TW:413868Neutral
TW:411662Neutral
TW:417560Neutral
TW:474156Neutral
TW:474753Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 73Outperform | TWD 1.86B | 12.15 | ― | 3.98% | -1.23% | 10.20% | |
| 68Neutral | TWD 2.15B | 15.66 | ― | 7.75% | -1.10% | -16.90% | |
| 62Neutral | TWD 1.82B | 2.38 | ― | 4.91% | 3.85% | 786.65% | |
| 60Neutral | TWD 2.09B | 13.16 | ― | 6.00% | 2.49% | 5.18% | |
| 56Neutral | TWD 2.09B | 42.95 | ― | 0.50% | 5.77% | 157.11% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 53Neutral | TWD 1.60B | -23.25 | ― | 3.32% | 4.56% | -172.55% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:4741 | Jetbest Corporation | 60.40 | 38.75 | 179.01% | |
| TW:4116 | BenQ Medical Technology Corp. | 40.70 | -3.48 | -7.87% | |
| TW:4138 | Dynamic Medical Technologies Inc. | 54.20 | -5.51 | -9.23% | |
| TW:4175 | MedFirst Healthcare Services, Inc. (TW) | 50.00 | -4.37 | -8.04% | |
| TW:4747 | Johnson Chemical Pharmaceutical Works Co., Ltd. | 15.80 | -15.92 | -50.19% | |
| TW:6527 | Crystalvue Medical Co Ltd | 72.90 | -5.63 | -7.16% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
